Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics
No Thumbnail Available
Click here to download
Date
2016
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
18F-FDG-PET/CT, neuroendocrine tumor, somatostatin receptor imaging, tumor biology, tumor heterogeneity
Source
Nuclear Medicine Communications, 2016. Vol. 37 (10): pp. 1030-1037